- Tests done on Rhesus Macau monkeys, immune system resembles humans
- This vaccine is being tested on humans too, participated in 1000 Volunteer Trials.
Researchers at Oxford University, UK, have tested the vaccine for the treatment of Kovid-19 on six monkeys. Test results have come out positive. This vaccine is also being tested on humans. About 1000 volunteers have participated in clinical trials.
The vaccine, named CHADOX1 NCOV-19, was tested on six Rhesus Macau monkeys. Tests in these monkeys will be able to know how the vaccine will affect humans, as both have similar immune systems. However, there is no guarantee that the results will be so good in humans.
The researchers reported that the monkeys infected with Kovid-19 were divided into two groups. During this, those who were injected with the vaccine were in better condition than others. Antibodies started to form in them within 14 days. This revealed that ‘CHADOX 1 NCOV-19’ had better results on Rhesus Macau monkeys.
Test done in America
According to a BBC report, the US government’s National Institutes of Health (NIH) and Oxford University conducted the test in the US. This vaccine has been created by researchers from the Oxford Vaccine Group and the Jenner Institute in Oxford.
Vaccine trial is going on on humans too
Researchers at Oxford University have begun testing the vaccine on humans as well. This test is to be conducted in three stages. Once the first phase results are positive, further testing will be started. Research is currently underway on 100 vaccines worldwide.